Jeff Yass’s MediciNova MNOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-13,100
Closed -$50K 13601
2021
Q3
$50K Sell
13,100
-40,400
-76% -$154K ﹤0.01% 12347
2021
Q2
$227K Sell
53,500
-14,600
-21% -$62.9K ﹤0.01% 11319
2021
Q1
$344K Buy
68,100
+24,000
+54% +$140K ﹤0.01% 10328
2020
Q4
$232K Sell
44,100
-21,200
-32% -$121K ﹤0.01% 9790
2020
Q3
$342K Buy
+65,300
New +$377K ﹤0.01% 8443
2017
Q2
Sell
-40,000
Closed -$240K 9574
2017
Q1
$240K Sell
40,000
-18,400
-32% -$111K ﹤0.01% 7735
2016
Q4
$352K Buy
+58,400
New +$411K ﹤0.01% 7665

Other funds holding MNOV

Jeff Yass's MNOV Position: Q2 2026 in Review

Jeff Yass reduced its MediciNova (MNOV) stake by 39% in Q2 2026, selling an estimated $23.6K and leaving 26,752 shares worth $35.3K. The position accounts for ﹤0.01% of the portfolio, ranked #12926.

Jeff Yass first reported a position in MNOV in Q1 2016 and has held it in 28 quarters since. The position peaked at $771K in Q1 2016. 29 funds tracked by Wall St. Rank hold MNOV as of Q2 2026.

  • Jeff Yass held 26,752 shares of MediciNova worth $35.3K as of Q2 2026.
  • Jeff Yass sold 17,174 MediciNova shares in Q2 2026, an estimated $23.6K.
  • MediciNova made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #12926 holding.
  • Jeff Yass first reported a position in MediciNova in Q1 2016 and has held it in 28 quarters since.
  • Jeff Yass's MediciNova position peaked at $771K in Q1 2016.
  • 29 funds tracked by Wall St. Rank held MediciNova as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.